Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related MGM
Macau Losing Streak Extends To 16th Month
Downtown Vegas Gaming Revenue Jumps 15% In August
MGM Resorts Is Lagging Its Brethren After Recent Chinese Rhetoric (Seeking Alpha)
Related FDP
America Wants More Organic Products Than Anyone Else: Here's How To Play It
Earnings Scheduled For April 28, 2015
Fresh Del Monte: A Good Produce (Seeking Alpha)

Pre-open movers US stock futures are higher this morning, as investors are awaiting housing market index. Futures for the Dow Jones Industrial Average surged 21 points to 13,969.00 and S&P 500 index futures rose 1.30 points to 1,518.40. Nasdaq 100 futures climbed 2.50 points to 2,763.75.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.61%, London's FTSE 100 Index gained 0.29%, German DAX 30 Index rose 0.79% and French CAC 40 Index climbed 1.10%.

Asian markets ended mixed, with Japan's Nikkei Stock Average falling 0.31%, China's Shanghai Composite dropping 1.60% and Australia's S&P/ASX 200 Index gaining 0.36%. Hong Kong's Hang Seng Index fell 1.02% and India's Sensex gained 0.69%.

Broker Recommendation Analysts at RBC Capital upgraded MGM Resorts International (NYSE: MGM) from “sector perform” to “outperform.” The target price for MGM Resorts has been raised from $13 to $16.

MGM Resorts shares gained 0.16% to $12.90 in pre-market trading.

Breaking news

  • Fresh Del Monte Produce (NYSE: FDP) reported a break-even profit for the fourth quarter. To read the full news, click here.
  • Today, Microsoft (NASDAQ: MSFT) announced that its highly popular email service,, is ready for primetime. To read the full news, click here.
  • Westlake Chemical (NYSE: WLK) reported a surge in its fourth-quarter profit. To read the full news, click here.
  • Regeneron Pharmaceuticals (NASDAQ: REGN) and Bayer HealthCare today announced that they have initiated a new Phase 3 trial to evaluate the efficacy and safety of EYLEA® (aflibercept) Injection in the treatment of Diabetic Macular Edema (DME) in Russia, China, and other Asian countries. To read the full news, click here.

Posted-In: RBC Capital US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (FDP + MGM)

Get Benzinga's Newsletters